418 related articles for article (PubMed ID: 25511119)
21. Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study.
Pratico AD; Longo L; Mansueto S; Gozzo L; Barberi I; Tiralongo V; Salvo V; Falsaperla R; Vitaliti G; La Rosa M; Leonardi S; Rotondo A; Avola N; Sgarlata D; Damiano A; Tirantello M; Anzelmo G; Cipolla D; Rizzo A; Russo A; Ruggieri M; Salomone S; Drago F
Curr Drug Saf; 2018; 13(3):200-207. PubMed ID: 29921210
[TBL] [Abstract][Full Text] [Related]
22. Drug utilization study in pediatric prescriptions of a university hospital in southern Brazil: off-label, unlicensed and high-alert medications.
Dos Santos L; Heineck I
Farm Hosp; 2012; 36(4):180-6. PubMed ID: 22030161
[TBL] [Abstract][Full Text] [Related]
23. Incidence of unlicensed and off-label prescription in children.
Langerová P; Vrtal J; Urbánek K
Ital J Pediatr; 2014 Feb; 40():12. PubMed ID: 24495454
[TBL] [Abstract][Full Text] [Related]
24. Adverse drug reactions and off-label drug use in paediatric outpatients.
Horen B; Montastruc JL; Lapeyre-Mestre M
Br J Clin Pharmacol; 2002 Dec; 54(6):665-70. PubMed ID: 12492616
[TBL] [Abstract][Full Text] [Related]
25. Off-label and unlicensed paediatric prescribing in a community setting: a prospective longitudinal cohort study in Malta.
Ellul IC; Grech V
Paediatr Int Child Health; 2014 Feb; 34(1):12-8. PubMed ID: 24502853
[TBL] [Abstract][Full Text] [Related]
26. Adverse drug reactions and off-label and unlicensed medicines in children: a prospective cohort study of unplanned admissions to a paediatric hospital.
Bellis JR; Kirkham JJ; Nunn AJ; Pirmohamed M
Br J Clin Pharmacol; 2014 Mar; 77(3):545-53. PubMed ID: 23919928
[TBL] [Abstract][Full Text] [Related]
27. [Off-label and unlicensed drug use: Results from a pilot study in a pediatric intensive care unit].
García-López I; Fuentes-Ríos JE; Manrique-Rodríguez S; M Fernández-Llamazares C
An Pediatr (Barc); 2017 Jan; 86(1):28-36. PubMed ID: 27151379
[TBL] [Abstract][Full Text] [Related]
28. Widespread off-label prescribing of topical but not systemic drugs for 350,000 paediatric outpatients in Stockholm.
Ufer M; Rane A; Karlsson A; Kimland E; Bergman U
Eur J Clin Pharmacol; 2003 Mar; 58(11):779-83. PubMed ID: 12634986
[TBL] [Abstract][Full Text] [Related]
29. [Drug prescriptions study in the outpatient setting: assessment of off-label uses in children].
Blanco-Reina E; Vega-Jiménez MA; Ocaña-Riola R; Márquez-Romero EI; Bellido-Estévez I
Aten Primaria; 2015; 47(6):344-50. PubMed ID: 25443768
[TBL] [Abstract][Full Text] [Related]
30. Off-label antidepressant use in children and adolescents compared with young adults: extent and level of evidence.
Czaja AS; Valuck R
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):997-1004. PubMed ID: 22760843
[TBL] [Abstract][Full Text] [Related]
31. Off-label drug prescriptions in French general practice: a cross-sectional study.
Drogou F; Netboute A; Giai J; Dode X; Darmon D; Kassai B; Letrilliart L
BMJ Open; 2019 Apr; 9(4):e026076. PubMed ID: 30967407
[TBL] [Abstract][Full Text] [Related]
32. Off-label antidepressant prescription in pediatric outpatients based on China Food and Drug Administration and Food and Drug Administration regulations: a Chinese retrospective study.
Deng S; Zhu X; Sun B; Hu J; Shang D; Chen W; Lu H; Ni X; Zhang M; Wang Z; Wen Y; Qiu C
Int Clin Psychopharmacol; 2018 May; 33(3):172-179. PubMed ID: 29505485
[TBL] [Abstract][Full Text] [Related]
33. [Off-label prescriptions in public psychiatric hospital practice].
Andréoli L; Gaudoneix M; Beauverie P; de Beaurepaire R
Therapie; 2013; 68(6):347-59. PubMed ID: 24246118
[TBL] [Abstract][Full Text] [Related]
34. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
Ellul IC; Grech V; Attard-Montalto S
Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
[TBL] [Abstract][Full Text] [Related]
35. Adverse drug reactions and off-label and unlicensed medicines in children: a nested case-control study of inpatients in a pediatric hospital.
Bellis JR; Kirkham JJ; Thiesen S; Conroy EJ; Bracken LE; Mannix HL; Bird KA; Duncan JC; Peak M; Turner MA; Smyth RL; Nunn AJ; Pirmohamed M
BMC Med; 2013 Nov; 11():238. PubMed ID: 24229060
[TBL] [Abstract][Full Text] [Related]
36. [High prevalence of off-label and unlicensed drug prescribing in a Brazilian intensive care unit].
Ferreira Lde A; Ibiapina Cda C; Machado MG; Fagundes ED
Rev Assoc Med Bras (1992); 2012; 58(1):82-7. PubMed ID: 22392321
[TBL] [Abstract][Full Text] [Related]
37. High prevalence of off-label and unlicensed paediatric prescribing in a hospital in Indonesia during the period Aug.-Oct. 2014.
Tukayo BLA; Sunderland B; Parsons R; Czarniak P
PLoS One; 2020; 15(1):e0227687. PubMed ID: 31935254
[TBL] [Abstract][Full Text] [Related]
38. Unlicensed and off-label drug use in an Irish neonatal intensive care unit: a prospective cohort study.
Kieran EA; O'Callaghan N; O'Donnell CP
Acta Paediatr; 2014 Apr; 103(4):e139-42. PubMed ID: 24397831
[TBL] [Abstract][Full Text] [Related]
39. Off-label drug use in pediatric anesthesia and intensive care according to official and pediatric reference formularies.
Doherty DR; Pascuet E; Ni A; Stewart P; Splinter W; Vaillancourt R
Can J Anaesth; 2010 Dec; 57(12):1078-88. PubMed ID: 20924803
[TBL] [Abstract][Full Text] [Related]
40. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
